Mechanistic studies had found that the induction of cellular stress in diabetic kidneys was blocked by FGF1 treatment, indicating that reduction of cellular stress is another potential crucial molecular mechanism during FGF1 treatment for DN. This evidence concerns the gene FGF1 and liver dysplastic nodule.